Poster Abstract Session:
51. C. difficile Diagnostics
Thursday, October 18, 2012: 12:30 PM-2:00 PM
Room: SDCC Poster Hall F-H

Topical Category: N. Infection Epidemiology and Prevention and P. Pediatric and Perinatal Infections

Tracks: Epidemiology and Infection Control, Pediatric ID

Presentations:

320
Increased Clostridium difficile (CD) Detection and Decreased Empiric Treatment/Ancillary Testing after switch from Toxin A/B Immunoassy to PCR for Diagnosis of CD Infection
Laurie Labuszewski, PharmD ; Urvashi Thakkar, PharmD ; Stuart Johnson, MD, FIDSA ; Paul Schreckenberger, PhD ; Jorge Parada, MD, MPH
Posters
  • ID Week final CD poster.pdf (544.0 kB)

  • 321
    Utility of Perirectal Swab Specimens for Diagnosis of Clostridium difficile Infection
    Sirisha Kundrapu, M.D. ; Venkata Sunkesula, M.D, M.S ; Lucy Jury, N.P. ; Ajay K. Sethi, PhD ; Curtis J. Donskey, MD

    324
    Regional Differences in Vancomycin-resistant enterococcus and C difficile co-Colonization Rates in Critically Ill Veterans
    Linda McKinley, RN, BSN, MPH, CIC ; Mary Hagle, RN, PhD ; Helene Moriarty, RN, PhD ; Tom Short, PhD ; Nasia Safdar, MD, PhD

    325
    Changes in Clostridium difficile Testing Practices and their Impact on Stool Rejection Policies across Multiple U.S. Laboratories
    Jessica Cohen, MPH ; Duncan MacCannell, PhD ; Leigh Ann Clark, MPH ; Wendy Bamberg, MD ; Rebecca Perlmutter, MPH ; John Dunn, DVM, PhD ; Joelle Nadle, MPH ; Stacy Holzbauer, DVM ; Carol Lyons, MPH ; Erin Phipps, DVM ; Ghinwa Dumyati, MD, FSHEA ; Zintars G. Beldavs, MS ; Fernanda Lessa, MD

    326
    The Nose Knows Not: Poor Predictive Value of Stool Sample Odor for Detection of Clostridium difficile
    Krishna Rao, MD ; Daniel Berland, MD ; Carol Young, MT(ASCP) ; Seth Walk, MS, PhD ; Duane Newton, PhD

    327
    Evaluation of a Commercial PCR Assay for Detection of Environmental Contamination with Clostridium difficile
    Abhishek Deshpande, M.D., Ph.D. ; Jennifer Cadnum, B.S. ; Brett Sitzlar, B.S. ; Sirisha Kundrapu, M.D. ; Curtis J. Donskey, MD
    Posters
  • Abhishek.pdf (155.3 kB)

  • 328
    Severe Clostridium difficile Infection in Patients with Negative Results for tcdB by the Xpert® C. difficile assay
    Jerome Leis, MD ; Wayne Gold, MD, FRCPC ; John Ng, PhD ; Zahir Hirji ; Dylan Pillai, MD, PhD ; George Broukhanski, PhD ; Paul Raggiunti ; Susy Hota, MD ; Allison McGeer, MD, FSHEA ; Susan Poutanen, MD, MPH

    329
    Does Empirical Clostridium difficile Infection (CDI) Therapy Result in False-Negative CDI Diagnostic Test Results?
    Venkata Sunkesula, M.D, M.S ; Sirisha Kundrapu, M.D. ; Curtis J. Donskey, MD

    330
    Prospective Evaluation of the Epidemiology of Clostridium difficile Colonization and Infection among Hematopoietic Stem Cell Transplant Recipients
    Varinia Urday-Cornejo, MD ; Christopher Croswell ; Teena Chopra, MD, MPH ; Alyssa Liubakka ; Jessica Cutright, BS ; Hossein Salimnia, PhD ; Paul Lephart, PhD ; Sanjay Revankar, MD ; Pranatharthi Chandrasekar, MD ; George Alangaden, MD

    331
    Multilocus sequence typing analysis of 85 C. difficile strains isolated from a teaching hospital in Houston Texas, September through December 2011
    Zhi-Dong Jiang ; Ravi Panchumarthi ; Kevin W. Garey, PharmD, M.S. ; Todd M. Lasco, PhD ; Jane Chen ; Herbert DuPont, MD, FIDSA

    332
    Clostridium difficile Whole Genome Sequencing Suggests Limited Transmission Arising From Mixed Infection
    David Eyre, BM, BCh ; Madeleine Cule, PhD ; David Griffiths, BSc ; Tim Peto, MB BS, DPhil ; A. Sarah Walker, PhD ; Daniel Wilson, DPhil

    333
    Title: Safety of Clostridium Difficile Testing Algorithm using Glutamate Dehydrogenase Antigen and Toxin Enzyme Immunoassay with Reflex PCR for Discordant Test
    Cecilia Big, MD ; David Sengstock, MD, MS ; Natasha Bagdasarian, MD, MPH ; Vijayalakshmi Nagappan, MD ; Padmaja Vemuri, MD ; David Weidendorf, MD ; Rama Thyagarajan, MD
    Posters
  • Slide1.JPG (1.2 MB)

  • 334
    Prevalence and Molecular Epidemiology of Clostridium difficile (CD) in Food and Companion Animals, Retail Meats, and Humans in Minnesota
    Megan K. Shaughnessy, MD ; Tim Snider, DVM ; Rocio Sepulveda ; David Boxrud, MS ; Elizabeth Cebelinski, BS ; Stacy Holzbauer, DVM ; Kirk Smith, DVM, PhD ; Jeff Bender, DVM MS DACVPM ; Francisco Diez-Gonzalez, PhD ; James R. Johnson, MD

    335
    Screening for Vancomycin Resistant Enterococcus (VRE) Colonization During Clostridum difficile Testing is Not Cost Effective at a Canadian Teaching Hospital
    Sunil Varghese, MD, MA ; Kathryn Suh, MD, MSc, FRCPC ; Natalie Bruce, RN, BScN, CIC ; Karam Ramotar, PhD ; Virginia Roth, MD

    336
    Toxin A/B EIA Compared to Molecular Amplification Testing for Clostridium Difficile: Cost and Resource Utilization Analyses
    Reda A. Awali, MD ; Brindha Gopala Krishnan, MD ; Harleen Kaur, MD ; Indu K. Chalana, MD ; Paula Robinson, RN ; Sanjay Revankar, MD ; Judy Moshos, BS, MT ; Paul Lephart, PhD ; Richard Fackler, BBA ; Keith Kaye, MD, MPH, FIDSA, FSHEA ; Teena Chopra, MD, MPH
    Posters
  • Poster_EIA vs MA.pdf (899.0 kB)

  • 337
    Comparative Analysis of Two Culture Media and PCR for the Detection of Toxigenic and Non-Toxigenic C. difficile
    Christopher Croswell ; Varinia Urday-Cornejo, MD ; Alyssa Liubakka ; Jessica Cutright, BS ; Hossein Salimnia, PhD ; Paul Lephart, PhD ; Teena Chopra, MD, MPH ; Pranatharthi Chandrasekar, MD ; George Alangaden, MD

    CME Credits:


    Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 17th with the exception of research findings presented at the IDWeek press conferences.